RECENT COMMENTS

Kathy Redmond: Readers may have noticed that ESO has deleted a number of comments on this article. This is because [...]   »Read more

Pongsri (Sex and cancer): I teach body image and sexuality in cancer survivors for specialty 4 month cancer nurse program. Thi [...]   »Read more

DR Jennifer L Scott (Sex and cancer): Togehter with my colleague Prof Karen Kayser I have published a review of RCT of interventions to en [...]   »Read more

Dr O. Abimbola Oluwatosin (Sex and cancer): I teach sexuality in Nursing at post graduate level. This article is very useful and will be added t [...]   »Read more

Dr. Yannis Vassiliou (political oncology): A great article, well done! I was deeply disappointed by the comments of the Turkish colleagues, wh [...]   »Read more

 

Article type: Masterpiece

Keywords: Ferdy Lejeune, TNF, immunology, .

This article has 0 comments

Facebook Twitter Share - Send - Print - Pdf

 

A very useful doctor

A very useful doctor

Ferdy Lejeune went into medicine to be ‘useful’, and he did well. Thousands of amputations have been avoided thanks to a technique he pioneered. His focus on tumour blood vessels and immunology helped pave the way for some of the most exciting areas of cancer research today. For Lejeune, however, ‘useful’ is as much a matter of finding out what doesn’t work as what does.

» Janet Fricker


To read the complete article please click on the pdf icon
 
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck and Novartis.